← FDA DRUG APPROVALS

FDA ANDA · ANDA090453

MOLINDONE HYDROCHLORIDE

Sponsor: EPIC PHARMA LLC

APPLICATION
ANDA090453
TYPE
ANDA
ORIGINAL APPROVAL
2015-03-20
LATEST ACTION
2025-01-22
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Prescription

Products

MOLINDONE HYDROCHLORIDEPrescription
MOLINDONE HYDROCHLORIDE 25MG · TABLET · ORAL
MOLINDONE HYDROCHLORIDEPrescription
MOLINDONE HYDROCHLORIDE 5MG · TABLET · ORAL
MOLINDONE HYDROCHLORIDEPrescription
MOLINDONE HYDROCHLORIDE 10MG · TABLET · ORAL

Approval history

2025-01-22Labeling · Supplement 11 · standardAP
2017-02-23Labeling · Supplement 4 · standardAP
2015-03-20OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →